This study supports the early presence of a gynecological oncologist at delivery when abnormally invasive placenta is suspected and demonstrates that a "call if needed" approach is not acceptable for these complex cases.

There are insufficient data available to draw conclusions on the effectiveness of timed intercourse for the outcomes of live birth, adverse events and clinical pregnancy. Timed intercourse may improve pregnancy rates (clinical or self-reported pregnancy, not yet confirmed by ultrasound) compared to intercourse without ovulation prediction. The quality of this evidence is low to very low and therefore findings should be regarded with caution. There is a high risk of publication bias, as one large study remains unpublished 8 years after recruitment finished. Further research is required, reporting clinically relevant outcomes (live birth, clinical pregnancy rates and adverse effects), to determine if timed intercourse is safe and effective in couples trying to conceive.

No abstract

(Acta Obstet Gynecol Scand. 2015;94:1380–1386) Research has established that one of the major causes of maternal morbidity and mortality is an abnormally invasive placenta (AIP). AIP occurs when all parts or particular parts of the placenta do not separate from the uterine wall following delivery; this includes placenta accreta, increta and percreta. Complications of surgery to treat this problem include urologic and bowel injury, sepsis, fistula formation, and complications associated with massive blood loss and transfusion. Hence the objective of this study was to assess the role of a gynecologic oncologist’s (GO) involvement in AIP cases with an emphasis on the surgical approach used and how this might affect maternal and neonatal morbidity.

No abstract